Consulting a healthcare provider is advisable
Summary Diabetes doesnt only deplete GSH it impairs enzymes in the glutathione system (like glutathione synthetase, -glutamylcysteine synthetase, glutathione peroxidase)
[1] The Use of Semaglutide in Patients With Renal Failure A Retrospective Cohort Study, Endocrine Practice, October 2024
When Combination Therapy May Be Appropriate and Safety Considerations GLP-1 plus DPP-4 combination therapy remains a niche strategy, reserved primarily for patients who have reached maximum tolerated GLP-1 doses, achieved partial glycemic control, and have contraindications to insulin or SGLT2 inhibitors
It shares structural similarities with liraglutide, but it has been modified to have a longer half-life and be even more resistant to DDP- 4 degradation
The duration of follow-up, the number of participants included, the older age and cardiovascular comorbidities may explain why an increased fracture risk was observed [81]